新香港六合彩开奖结果

In his ,听笔谤辞蹿别蝉蝉辞谤听Lianos argues that听the competition assessment and the remedies鈥� package put forward by the European Commission suffer from major flaws, in terms of prior beliefs, assumptions, overall design and interpretation of the provisions of the European Merger Control Regulation and the EU Treaties.听

The merger between Bayer and Monsanto will certainly negatively affect innovation competition听in a number of product markets,听and more broadly the direction of innovation towards a GMO and chemical-centred model of agriculture that contravenes to the EU鈥檚 commitment to environmental protection and sustainability.听

The competition law remedy put forward by the European Commission, the creation of a fourth integrated platform under BASF, seems a quite risky bet, first over the ability and incentive of BASF to compete intensively with the other three integrated platforms, to the extent that the industry is marked by various forms of contractual consolidation and stealth concentration through common ownership, and secondly, over the way the current 鈥渋ntegrated鈥� platforms market configuration will enable new General Purpose Technologies, such as Big Data and gene-editing, to disrupt the competitive landscape in the industry and offer alternative directions for the development of innovation, that would be more in phase with the aims of the EU.
听

(Professor Lianos from around 32 min 15)

听